To include your compound in the COVID-19 Resource Center, submit it here.

Collins: NIH's hands tied in drug pricing

NIH Director Francis Collins did not offer many solutions for enforcing what he called "reasonable pricing" by drug manufacturers who use taxpayer-funded research, when questioned by Sen.

Read the full 279 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE